Clinical Application of Circulating Tumor Cells and Circulating Tumor DNA in Uveal Melanoma

PURPOSE: To evaluate the feasibility of using circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) for the management of uveal melanoma (UM). PATIENTS AND METHODS: Low-coverage whole-genome sequencing was used to determine somatic chromosomal copy number alterations (SCNAs) in primary UM...

Descripción completa

Detalles Bibliográficos
Autores principales: Beasley, Aaron, Isaacs, Timothy, Khattak, Muhammad A., Freeman, James B., Allcock, Richard, Chen, Fred K., Pereira, Michelle R., Yau, Kyle, Bentel, Jaqueline, Vermeulen, Tersia, Calapre, Leslie, Millward, Michael, Ziman, Melanie R., Gray, Elin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2018
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446501/
https://www.ncbi.nlm.nih.gov/pubmed/32913999
http://dx.doi.org/10.1200/PO.17.00279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446501/
https://www.ncbi.nlm.nih.gov/pubmed/32913999
http://dx.doi.org/10.1200/PO.17.00279

Ejemplares similares